about
Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroidCloning of a Leishmania major gene encoding for an antigen with extensive homology to ribosomal protein S3a.Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations.Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomasPeptide Anchor for Folate-Targeted Liposomal Delivery.Assessment of liposome disruption to quantify drug delivery in vitro.Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis.Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.Intragenic mutations in thyroid cancer.Vacuole-mitochondrial cross-talk during apoptosis in yeast: a model for understanding lysosome-mitochondria-mediated apoptosis in mammals.Colorectal cancer-related mutant KRAS alleles function as positive regulators of autophagy.Design of liposomal formulations for cell targeting.Folate-targeted nanoparticles for rheumatoid arthritis therapy.Enhancing Methotrexate Tolerance with Folate Tagged Liposomes in Arthritic Mice.The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside.RAF-1 promotes survival of thyroid cancer cells harboring RET/PTC1 rearrangement independently of ERK activation.Size controlled protein nanoemulsions for active targeting of folate receptor positive cells.Cathepsin D protects colorectal cancer cells from acetate-induced apoptosis through autophagy-independent degradation of damaged mitochondria.Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells.Folic acid-tagged protein nanoemulsions loaded with CORM-2 enhance the survival of mice bearing subcutaneous A20 lymphoma tumors.Frequency of TERT promoter mutations in human cancers.Yeast as a tool to explore cathepsin D function.Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate.Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells.BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations.Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines.A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation.Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.Characterization of acetate transport in colorectal cancer cells and potential therapeutic implications.p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin.Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray.Liposome and protein based stealth nanoparticles.In vitro induction of melanin synthesis and extrusion by tamoxifen.Telomere erosion triggers growth arrest but not cell death in human cancer cells retaining wild-type p53: implications for antitelomerase therapy.Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests.The Yeast Saccharomyces cerevisiae as a Model for Understanding RAS Proteins and their Role in Human Tumorigenesis.A stem cell role for thyroid solid cell nests.KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progressionType and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressivenessBRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC
P50
Q24796416-53C64E1C-F66D-4395-AD62-A81F5C4147D6Q30813955-7C9346E4-F247-4B35-AF4C-6B84A1D82689Q33514138-B9F284C2-D0F1-4755-A166-3621C2B2605FQ35731037-B005EEAB-45AE-4C7E-A4CC-C0B811A6E18EQ35737473-B3482356-3EFB-4887-851D-B2FA2D82A3B4Q35847441-781964CD-8F86-4229-8D20-F93E3718FF44Q36086546-865D40BE-7ED2-4B38-A3DD-F724FE9BEBA3Q36615843-B1B9CF72-2412-4820-BFDE-AD9DD88B3B97Q37172760-9FDC45BD-2752-4BF0-B0A8-C6274C06BE88Q37936571-26B9346B-909A-4862-83A3-E58AB56878B9Q38260444-056D65DE-8131-49BB-94D0-8E1AE4530664Q38603806-EEE12632-E548-4DFF-9503-C94AADC1FF7BQ38687596-B9BF8E00-EA4B-4DBE-BC54-8F7446F1AB1FQ38824184-2D9674E6-5142-49CA-A4A5-EC63BDFFA58AQ38837920-F2B2C8E2-AD8B-4E03-A6AC-1481F87CE23FQ38844306-7F31060E-CF76-4DC7-A111-858B0940D673Q38846398-23CE8C64-DCB8-4F0D-826D-444D3247CEDFQ38862588-F67101B6-D30C-4BCC-9CCE-BEF51B73256BQ38869917-10B5AE65-DA15-4F7A-8B79-D3F0530AD954Q38897316-8831A3BD-C70E-4E96-B34B-D681B4FF3372Q39120274-4FDBEDC6-3F73-4B2F-BF2C-E91F674A9371Q39208117-747FE10B-B6C4-445E-9206-A5FAD4D47539Q39393508-7C361898-2DB3-4405-B729-F0ECCC05E69EQ39864252-9905780E-5809-45ED-B629-A9FCB4D3DD79Q40031893-7125DCB1-9631-4F6E-91B7-6B99305CF425Q40088475-098B3D91-3B8F-40E5-905F-8D08C55E9762Q40135421-0F6E56C9-FDFC-402B-B650-604F119A333CQ40406797-BE34DDDA-C1BB-496D-86DB-E97C4E3AA01EQ42317480-FDFB3EED-4B83-411F-9324-16ACF622D606Q42435716-C33C2441-35C9-4BB2-A778-FA691991A73BQ42445219-6A2559A3-4979-4F0F-8006-F22C4F97A2AFQ44916613-44035DAE-7FA9-4A03-AF69-CA967326E2D3Q45816763-C61B9831-F2C7-4531-A269-8AC67F76C218Q47817565-F558FFF7-3339-4A2C-95D0-5960CC4BFA7DQ47878443-F285071F-E3D8-42B8-8A38-C18E507F628DQ49798156-A6A6A8E6-C0E2-4E2E-B098-FD495A134D97Q53357270-8F5355B8-46DC-446F-8A84-7903024B9648Q58966086-B02DCCB3-D71D-4596-BF6C-86697268BAA7Q60527135-BE3C2A7E-34CD-40E8-85DD-D5C4E5DC65AEQ60527142-B5039E4F-DCF4-4196-AA69-0FCB8887CD5C
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ana Preto
@ast
Ana Preto
@en
Ana Preto
@es
Ana Preto
@nl
Ana Preto
@pt
type
label
Ana Preto
@ast
Ana Preto
@en
Ana Preto
@es
Ana Preto
@nl
Ana Preto
@pt
prefLabel
Ana Preto
@ast
Ana Preto
@en
Ana Preto
@es
Ana Preto
@nl
Ana Preto
@pt
P1053
H-8112-2012
P106
P1153
6602508305
P21
P31
P3829
P496
0000-0002-7302-0630